This advantage may stem from tirzepatides multiple mechanisms of action, including promoting insulin secretion and suppressing appetite, leading to excellent performance in both glycemic control and weight management (as observed in the SURPASS-3 and SURPASS-4 trials)
Fortunately, a new wave of treatments is on the horizon
It is important to note that rapid improvement in glycemic control with any diabetes medication, including semaglutide, can occasionally trigger a condition called treatment-induced neuropathy of diabetes
Nahar, S., Chowdhury, A., Ogura, T
Of the 119/48 total intermolecular NOEs for p53 TAD2 -FOXO4-DRI/p53 TAD2 -FOXO4 FH complexes only 19/2 NOEs could be assigned unambiguously